Hepatology

The American College of Gastroenterology recently released new guidelines, the first in 10 years, on the evaluation of abnormal liver chemistries.

A new study extended the period of treatment for patients with Hepatitis C on Sofosbuvir and Ribavirin to test whether SVF12 rates can be attained in real-life.

Researchers assessed direct-acting antiviral agents and availability of funding to determine the impact on ability to treat and cure veterans with hepatitis C virus.

A fixed dose of elbasvir-grazoprevir, with or without ribavirin, is well tolerated in patients with hepatitis C virus genotypes 1, 4, or 6.

A new study assessed the impact of treatment status on the risk of hepatocellular carcinoma in patients with hepatitis C virus.

A recent study aimed to determine the impact of treatment adherence to sofosbuvir-based regimens on virological outcomes in patients with hepatitis C virus.

Research discussed at an international symposium suggests that treating people who use drugs and have hepatitis C virus can reduce the prevalence of the infection. However, barriers prevent this population...

A new test uses urine samples rather than blood to detect infection with the hepatitis C virus.

Two recent studies examined the effects on sustained virologic response rates in patients with genotypes 1-6 hepatitis C virus infection treated with sofosbuvir and velpatasvir.

There are some epidemics of liver disease that are worthy of contemporary notice. One of note is the hepatitis C infection.